Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Hersh, Adam L ^a   Shapiro, Daniel J ^b   Newland, Jason G ^c   Polgreen, Philip M ^d   Beekmann, Susan E ^d   Shah, Samir S ^e,f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; LINEZOLID; MACROLIDE; PENICILLIN G; SULTAMICILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CHILD HOSPITALIZATION; COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; CONSULTATION; CONTROLLED STUDY; DRUG INFORMATION; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; PEDIATRICIAN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; TREATMENT RESPONSE; COMMUNICABLE DISEASE; DRUG EFFECT; INFORMATION PROCESSING; MICROBIOLOGY; PNEUMONIA;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DATA COLLECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; VANCOMYCIN;

EID: 79957842464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020325     Document Type: Article

References (27)

1. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS, (2010) National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 126: 204-213.
2. Gerber JS, Newland JG, Coffin SE, Hall M, Thurm C, et al. (2010) Variability in Antibiotic Use at Children's Hospitals. Pediatrics.
3. Grijalva CG, Nuorti JP, Zhu Y, Griffin MR, (2010) Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 50: 805-813.
4. Li ST, Tancredi DJ, (2010) Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 125: 26-33.
5. Centers for Disease Control and Prevention, Active Bacterial Core Surveillance. Available: http://www.cdc.gov/abcs/reports-findings/surv-reports.html. Accessed 2010 Nov 10.
6. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, et al. (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52: e18-55.
7. Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, et al. (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113: 1735-1740.
8. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, et al. (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25: 250-254.
9. Kollef MH, (2008) Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 47 (Suppl 1): S3-13.
10. Muszynski JA, Knatz NL, Sargel CL, Fernandez SA, Marquardt DJ, et al. (2010) Timing of Correct Parenteral Antibiotic Initiation and Outcomes From Severe Bacterial Community-acquired Pneumonia in Children. Pediatr Infect Dis J.
11. Patel SJ, Rosen E, Zaoutis T, Prasad P, Saiman L, (2010) Neonatologists' perceptions of antimicrobial resistance and stewardship in neonatal intensive care units. Infect Control Hosp Epidemiol 31: 1298-1300.
12. Pogue JM, Alaniz C, Carver PL, Pleva M, Newton D, et al. (2011) Role of Unit-Specific Combination Antibiograms for Improving the Selection of Appropriate Empiric Therapy for Gram-Negative Pneumonia. Infect Control Hosp Epidemiol 32: 289-292.
13. Newland JG, Hersh AL, (2010) Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J 29: 862-863.
14. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159-177.
15. Hersh AL, Beekmann SE, Polgreen PM, Zaoutis TE, Newland JG, (2009) Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 30: 1211-1217.
16. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, et al. (2010) Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema. Pediatr Infect Dis J.
17. Mermel LA, Jefferson J, Devolve J, (2008) Knowledge and use of cumulative antimicrobial susceptibility data at a university teaching hospital. Clin Infect Dis 46: 1789.
18. Williams DJ, Hall M, Brogan TV, Farris RW, Myers AL, et al. (2011) Influenza Coinfection and Outcomes in Children With Complicated Pneumonia. Arch Pediatr Adolesc Med.
19. Metlay JP, Shea JA, Crossette LB, Asch DA, (2002) Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 17: 87-94.
20. Rosen J, Beekmann S, Polgreen P, Moore M, (2010) Barriers to intravenous penicillin use for treatment of nonmeningitis pneumococcal disease. J Clin Microbiol 48: 3372-3374.
21. Cardoso MR, Nascimento-Carvalho CM, Ferrero F, Berezin EN, Ruvinsky R, et al. (2008) Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia. Arch Dis Child 93: 221-225.
22. Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, et al. (2006) Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Pharmacoepidemiol Drug Saf 15: 1-9.
23. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, et al. (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37: 230-237.
24. Kaplan SL, (2005) Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 24: 457-458.
25. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG, (2010) Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics 125: e1294-1300.
26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (Suppl 2): S27-72.
27. Mulholland S, Gavranich JB, Chang AB, (2010) Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev pp. CD004875.